Tocilizumab Efficacy Across Inflammatory Subphenotypes in COVID-19-Related Acute Respiratory Distress Syndrome.
Saved in:
| Title: | Tocilizumab Efficacy Across Inflammatory Subphenotypes in COVID-19-Related Acute Respiratory Distress Syndrome. |
|---|---|
| Authors: | Filippini DFL; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Khyali J; Department of Intensive Care Medicine, Erasmus MC, Erasmus University Rotterdam, Rotterdam, The Netherlands., Janssen M; Department of Intensive Care Medicine, Erasmus MC, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Department of Internal Medicine, Erasmus MC, Erasmus University Rotterdam, Rotterdam, The Netherlands., Rademaker E; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands., Cremer OL; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands., van der Poll T; Center for Infection and Molecular Medicine (C.I.M.M.), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Amstel RBE; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Endeman H; Department of Intensive Care Medicine, Erasmus MC, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Department of Intensive Care Medicine, OLVG, Amsterdam, The Netherlands., Bos LDJ; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands. |
| Corporate Authors: | Amsterdam UMC COVID-19 Biobank Study Group |
| Source: | Critical care explorations [Crit Care Explor] 2026 Mar 16; Vol. 8 (3), pp. e1392. Date of Electronic Publication: 2026 Mar 16 (Print Publication: 2026). |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101746347 Publication Model: eCollection Cited Medium: Internet ISSN: 2639-8028 (Electronic) Linking ISSN: 26398028 NLM ISO Abbreviation: Crit Care Explor Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41837874 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tocilizumab Efficacy Across Inflammatory Subphenotypes in COVID-19-Related Acute Respiratory Distress Syndrome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Filippini+DFL%22">Filippini DFL</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Khyali+J%22">Khyali J</searchLink>; Department of Intensive Care Medicine, Erasmus MC, Erasmus University Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Janssen+M%22">Janssen M</searchLink>; Department of Intensive Care Medicine, Erasmus MC, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Department of Internal Medicine, Erasmus MC, Erasmus University Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rademaker+E%22">Rademaker E</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cremer+OL%22">Cremer OL</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Poll+T%22">van der Poll T</searchLink>; Center for Infection and Molecular Medicine (C.I.M.M.), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Amstel+RBE%22">van Amstel RBE</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Endeman+H%22">Endeman H</searchLink>; Department of Intensive Care Medicine, Erasmus MC, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Department of Intensive Care Medicine, OLVG, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bos+LDJ%22">Bos LDJ</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Amsterdam+UMC+COVID-19+Biobank+Study+Group%22">Amsterdam UMC COVID-19 Biobank Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101746347%22">Critical care explorations</searchLink> [Crit Care Explor] 2026 Mar 16; Vol. 8 (3), pp. e1392. <i>Date of Electronic Publication: </i>2026 Mar 16 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%22">Wolters Kluwer Health </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101746347 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2639-8028 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226398028%22">26398028 </searchLink><i>NLM ISO Abbreviation: </i>Crit Care Explor <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41837874 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/CCE.0000000000001392 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1392 Titles: – TitleFull: Tocilizumab Efficacy Across Inflammatory Subphenotypes in COVID-19-Related Acute Respiratory Distress Syndrome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Filippini DFL – PersonEntity: Name: NameFull: Khyali J – PersonEntity: Name: NameFull: Janssen M – PersonEntity: Name: NameFull: Rademaker E – PersonEntity: Name: NameFull: Cremer OL – PersonEntity: Name: NameFull: van der Poll T – PersonEntity: Name: NameFull: van Amstel RBE – PersonEntity: Name: NameFull: Endeman H – PersonEntity: Name: NameFull: Bos LDJ IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 03 Text: 2026 Mar 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2639-8028 Numbering: – Type: volume Value: 8 – Type: issue Value: 3 Titles: – TitleFull: Critical care explorations Type: main |
| ResultId | 1 |